ATCC Announces Award from National Institute of Allergy and Infectious Diseases to Support Its Preclinical Services for Biopharmaceutical Product Development
MANASSAS, Va.--(BUSINESS WIRE)--Nov 7, 2023--<a ...
MANASSAS, Va.--(BUSINESS WIRE)--Nov 7, 2023--<a ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nov 7, 2023--Whiterabbit.ai, an AI-technology company dedicated to making late-stage diseases a rarity, today announced its collaboration with the American College of Radiology 庐 (ACR 庐 ) Data Science Institute鈩� (DSI鈩�) to make its AI-driven breast ...
PRINCETON, N.J.--(BUSINESS WIRE)--Nov 7, 2023--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report third quarter 2023 financial results on November ...
FRANKLIN, Tenn.--(BUSINESS WIRE)--Nov 7, 2023--<a ...
MONTVALE, N.J., Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a peptide-nucleic acid-based broad spectrum immune regulating agent that acts on both key ...
WALTHAM, Mass.--(BUSINESS WIRE)--Nov 7, 2023--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management ...